Amplification and expression of the c-myc oncogene in human lung cancer cell lines
about
A novel c-Myc-responsive gene, JPO1, participates in neoplastic transformationSmall-molecule antagonists of Myc/Max dimerization inhibit Myc-induced transformation of chicken embryo fibroblastsPolyphenol Compound as a Transcription Factor InhibitorExpression of pancreatic secretory trypsin inhibitor gene in neoplastic tissuesSALL4 is a new target in endometrial cancerThe c-Myc target gene Rcl (C6orf108) encodes a novel enzyme, deoxynucleoside 5'-monophosphate N-glycosidaseThe genetic landscape of mutations in Burkitt lymphoma.Reduced levels of XPA, ERCC1 and XPF DNA repair proteins in testis tumor cell lines.Effect of proline analogues on activity of human prolyl hydroxylase and the regulation of HIF signal transduction pathway.MYC oncogenes and human neoplastic disease.Clinicopathologic and prognostic significance of c-MYC copy number gain in lung adenocarcinomas.Modeling human lung cancer in mice: similarities and shortcomings.A common copy-number breakpoint of ERBB2 amplification in breast cancer colocalizes with a complex block of segmental duplications.MYC Deregulation in Primary Human Cancers.Computational method for estimating DNA copy numbers in normal samples, cancer cell lines, and solid tumors using array comparative genomic hybridization.Lung cancer cell lines as tools for biomedical discovery and researchRapid Identification of Therapeutic Targets in Hematologic Malignancies via Functional Genomics.Genetic alterations of multiple tumor suppressors and oncogenes in the carcinogenesis and progression of lung cancer.Targeting lung cancer through inhibition of checkpoint kinases.Oncogenic role of EAPII in lung cancer development and its activation of the MAPK-ERK pathway.Initiation and characterization of small cell lung cancer patient-derived xenografts from ultrasound-guided transbronchial needle aspirates.Knockdown of SUMO-activating enzyme subunit 2 (SAE2) suppresses cancer malignancy and enhances chemotherapy sensitivity in small cell lung cancer.Pathogenesis of lung cancer: 100 year report.The DNA methylation landscape of small cell lung cancer suggests a differentiation defect of neuroendocrine cellsQueuosine modification of tRNA: its divergent role in cellular machinery.Cytotoxic effects of fascaplysin against small cell lung cancer cell lines.SNP rs10248565 in HDAC9 as a novel genomic aberration biomarker of lung adenocarcinoma in non-smoking women.Oncogenes, growth factors, and cell signaling in mouse lung tumors: an overview.Gene amplification in human lung cancer. The myc family genes and other proto-oncogenes and growth factor genes.Recessive oncogenes in lung cancer.Autophagy and its function in radiosensitivity.Tumor markers in human biopsy material.miR-342-3p regulates MYC transcriptional activity via direct repression of E2F1 in human lung cancer.Down-regulation of LATS2 in non-small cell lung cancer promoted the growth and motility of cancer cells.miR-494 acts as an anti-oncogene in gastric carcinoma by targeting c-myc.Autoantibodies to c-myc protein: elevated levels in patients with African Burkitt's lymphoma and normal Ghanians.The Role of c-MYC in B-Cell Lymphomas: Diagnostic and Molecular AspectsMYC-Master Regulator of the Cancer Epigenome and Transcriptome.Down-regulation of c-Myc expression inhibits the invasion of bile duct carcinoma cells.Cytostatic effect of novel mTOR inhibitor, PRP-1 (galarmin) in MDA 231 (ER-) breast carcinoma cell line. PRP-1 inhibits mesenchymal tumors.
P2860
Q24291788-A1B30B87-0698-4157-B3DF-255CCC700C4CQ24292464-BFB64599-B7DF-4EE0-9B28-6898174305FEQ26777064-9B943FF9-B87F-4A08-A766-2CFA15759811Q28285642-D609E04A-F908-4A19-8754-37576100FE20Q28303958-5D458F89-28BD-4783-AF47-A95C1160B165Q28575753-F9F94481-EBBE-42F3-973D-80C334AA6B54Q30453771-35024356-7655-4B7D-A398-4252F1334DFEQ30760649-176963FC-3605-4DFA-85FB-79FEBDEDEF0DQ31159179-0EC0D41C-046D-47B8-887F-E6713FEF0C9EQ33667340-59A9B49B-F0D8-4EAE-9410-4C2022D10456Q33682954-49EF3804-2075-42CE-8AA5-F6412FE0DF91Q33739273-DD8BE2CB-862A-4D95-897A-F1CEB157C1F8Q33739397-EDBFB3A0-2013-4123-A324-87007BA7B893Q33836755-4B00E745-469A-4C79-973D-18FB1BD361A2Q34038213-203E3518-BF2D-42DA-ABA6-51E6D708F714Q34110617-2F4C215C-A685-4C29-88C7-19640AD54676Q34654334-2FFB30DB-45DE-4647-AAD6-B72501729E95Q34963574-1E14B18E-74D5-4410-B00E-AE7D5E7898E7Q35128547-43BCA425-7C8F-41EE-94C5-347BBE6110ACQ35561919-D8A02521-3132-4A3F-B8CC-AB9C1A02E548Q35587164-B55817EE-6577-4701-A7B2-1785D0E7349AQ35789345-CBA83E8A-E5A9-4456-B460-E946613CA0F4Q36233709-C43F50F1-3AE1-4541-8EF0-CB3FB71B63F1Q36763079-2CBF5791-C8E2-4D94-B3A0-E40FF7E8DB36Q37635276-5479859E-9E5E-4803-816D-A193FADAAA50Q37666991-974A447B-3C28-4BD5-B3EB-DB711A025F94Q37714736-B73C2272-FDBB-4A06-891E-35696BA72858Q37760561-4122278D-CE82-4267-89EF-2F0BB8697753Q37900028-53517930-445C-4165-80F7-FC5CFABD6D38Q37900032-0BE0A05A-314F-40E0-BE17-8C58DC39E92AQ38462513-4BBBBE3F-65F6-4A10-8FF6-DF1032175783Q38729642-493436D5-E3C9-46CE-86EB-A7AB03202120Q38826529-BCCBE322-7527-4D97-8FA6-7F3E76CECB70Q38940931-1DAE8FA5-EB4D-4FE8-947F-FE3A9AE15569Q39017073-D1791605-437B-4657-9C6E-B8924427F445Q39156371-7EC4AE2A-1B72-4089-BB8B-F977C5555A42Q39221506-A7BB3B23-B047-48FA-9B5C-5F08AEABD80FQ39306981-E0932D1D-F8C3-485B-AE69-10A2BFC606D9Q39545248-325595A9-6B86-477D-BE36-A808BFA4E8A5Q39558447-7990A813-C40A-4412-9BFB-618AED59C3CA
P2860
Amplification and expression of the c-myc oncogene in human lung cancer cell lines
description
article publié dans la revue scientifique Nature
@fr
scientific article published in Nature
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в Nature в листопаді 1983
@uk
name
Amplification and expression of the c-myc oncogene in human lung cancer cell lines
@en
Amplification and expression of the c-myc oncogene in human lung cancer cell lines
@nl
type
label
Amplification and expression of the c-myc oncogene in human lung cancer cell lines
@en
Amplification and expression of the c-myc oncogene in human lung cancer cell lines
@nl
prefLabel
Amplification and expression of the c-myc oncogene in human lung cancer cell lines
@en
Amplification and expression of the c-myc oncogene in human lung cancer cell lines
@nl
P2093
P356
P1433
P1476
Amplification and expression of the c-myc oncogene in human lung cancer cell lines
@en
P2093
P2888
P304
P356
10.1038/306194A0
P407
P577
1983-11-01T00:00:00Z
P6179
1018066577